Patents by Inventor Marc BONNIN

Marc BONNIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TLR3 ligands that activate both epithelial and myeloid cells
    Patent number: 11525135
    Abstract: The invention relates to a composition comprising a double-stranded RNA (dsRNA) having two complementary strands, comprising at least one block of poly A and the complementary block of poly U, each strand having a length of between 50 and 200 bases, preferably between 55 and 200 bases, and a pharmaceutically acceptable vehicle, carrier or excipient, for use in a method of treating a cancer expressing a TLR3 receptor.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: December 13, 2022
    Assignee: TOLLYS
    Inventors: Marc Bonnin, Sylvain Thierry
  • TLR3 LIGANDS THAT ACTIVATE BOTH EPITHELIAL AND MYELOID CELLS
    Publication number: 20200080084
    Abstract: The invention relates to a composition comprising a double-stranded RNA (dsRNA) having two complementary strands, comprising at least one block of poly A and the complementary block of poly U, each strand having a length of between 50 and 200 bases, preferably between 55 and 200 bases, and a pharmaceutically acceptable vehicle, carrier or excipient, for use in a method of treating a cancer expressing a TLR3 receptor.
    Type: Application
    Filed: November 6, 2019
    Publication date: March 12, 2020
    Inventors: Marc BONNIN, Sylvain THIERRY